254 related articles for article (PubMed ID: 32859404)
1. [Use of synthetic substances in France and in Europe].
Debruyne D; Monzon E; Perino J; Haramburu F; Daveluy A; Lazès-Charmetant A; Giraudon I
Therapie; 2021; 76(3):221-228. PubMed ID: 32859404
[TBL] [Abstract][Full Text] [Related]
2. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
[TBL] [Abstract][Full Text] [Related]
3. The clinical challenges of synthetic cathinones.
Schifano F; Napoletano F; Arillotta D; Zangani C; Gilgar L; Guirguis A; Corkery JM; Vento A
Br J Clin Pharmacol; 2020 Mar; 86(3):410-419. PubMed ID: 31674690
[TBL] [Abstract][Full Text] [Related]
4. Synthetic cathinones: a new public health problem.
Karila L; Megarbane B; Cottencin O; Lejoyeux M
Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
[TBL] [Abstract][Full Text] [Related]
5. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
Yu WJ; Cottler L; Li JH
J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
[TBL] [Abstract][Full Text] [Related]
6. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
7. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
[No Abstract] [Full Text] [Related]
8. The Growing Problem of New Psychoactive Substances (NPS).
Madras BK
Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
[TBL] [Abstract][Full Text] [Related]
9. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
Gray R; Bressington D; Hughes E; Ivanecka A
J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
[TBL] [Abstract][Full Text] [Related]
11. Synthetic drugs of abuse.
Tamama K
Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
[TBL] [Abstract][Full Text] [Related]
12. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
Batisse A; Eiden C; Peyriere H; Djezzar S;
Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
[TBL] [Abstract][Full Text] [Related]
13. New psychoactive substances of natural origin: A brief review.
Feng LY; Battulga A; Han E; Chung H; Li JH
J Food Drug Anal; 2017 Jul; 25(3):461-471. PubMed ID: 28911631
[TBL] [Abstract][Full Text] [Related]
14. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
Strube J; Schaper A
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
[TBL] [Abstract][Full Text] [Related]
15. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cathinones: an evolving class of new psychoactive substances.
Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
[TBL] [Abstract][Full Text] [Related]
17. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.
Evans-Brown M; Sedefov R
Handb Exp Pharmacol; 2018; 252():3-49. PubMed ID: 30194542
[TBL] [Abstract][Full Text] [Related]
18. New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study.
de Souza Boff B; Silveira Filho J; Nonemacher K; Driessen Schroeder S; Dutra Arbo M; Rezin KZ
Forensic Sci Int; 2020 Jan; 306():110002. PubMed ID: 31864775
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives.
Radaelli D; Manfredi A; Zanon M; Fattorini P; Scopetti M; Neri M; Frisoni P; D'Errico S
Curr Neuropharmacol; 2021; 19(11):2038-2048. PubMed ID: 33845747
[TBL] [Abstract][Full Text] [Related]
20. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
